Changes in ultraviolet a radiation-induced thymidine dimers and erythema after oral nicotinamide or polypodium leucotomos extract in healthy volunteers: a randomized intraindividual trial.
- 2026-03-16
- Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 25(5)
- Aheen Faisal
- C M Lerche
- T Douki
- P A Philipsen
- C Pihl
- T Gregersen
- J R Granborg
- P Bjerring
- M Haedersdal
- S R Wiegell
- PubMed: 41838346
- DOI: 10.1007/s43630-026-00884-2
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Population
- 50 healthy volunteers (phototypes I-III)
- Methods
- In this intraindividual trial, 50 healthy volunteers were randomized (1:1) to receive either NAM (2000 mg daily) or PL (Heliocare Advanced: 480 mg daily) for 30 days
- Blinding
- Open-label
- Duration
- 30 days
- Funding
- Unclear
Background
Nicotinamide (NAM) and Polypodium leucotomos extract (PL) have demonstrated photoprotective effects, but their role in preventing UVA-induced DNA damage in humans remains unclear.Objective
To evaluate the effects of oral NAM and PL on UVA-induced erythema and thymidine dimer (TT-dimer) formation.Methods
In this intraindividual trial, 50 healthy volunteers (phototypes I-III) were randomized (1:1) to receive either NAM (2000 mg daily) or PL (Heliocare Advanced: 480 mg daily) for 30 days. UVA-induced erythema, assessed by minimal erythema dose (MED), and TT-dimers, quantified in urine and skin biopsies, were measured before and after treatment with NAM or PL.Results
Both NAM and PL increased MED by 26%. With a median MED of 27.7 J/cm² (13.4-51.1 J/cm²) pre-NAM and 34.8 J/cm² (13.4-62.5 J/cm²) post-NAM (p = 0.0008). And A median MED of 27.7 J/cm² (13.4-51.1 J/cm²) pre-PL and 34.8 J/cm² (16.4-62.5 J/cm²) post-PL (p = 0.0002). Neither treatment reduced UVA-induced TT-dimers in skin (NAM: p = 0.15; PL: p = 0.15) or urine (NAM: p = 0.89; PL: p = 0.30).Limitations
NAM and PL were not administered during the urine collection-period, which limited the assessment of the treatment's effect after radiation.Conclusion
UVA-induced erythema was significantly reduced by PL and NAM, but neither had measurable effects on TT-dimer induction. Further research should investigate the relation between these findings and the chemopreventive effect of NAM and PL on skin cancer.Research Insights
Neither treatment reduced UVA-induced TT-dimers in skin (NAM: p = 0.15; PL: p = 0.15)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 480 mg daily (Heliocare Advanced)
Both NAM and PL increased MED by 26%. And A median MED of 27.7 J/cm² (13.4-51.1 J/cm²) pre-PL and 34.8 J/cm² (16.4-62.5 J/cm²) post-PL (p = 0.0002).
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 480 mg daily (Heliocare Advanced)
Neither treatment reduced UVA-induced TT-dimers in ... urine (NAM: p = 0.89; PL: p = 0.30).
- Effect
- Neutral
- Effect size
- Small
- Dose
- 480 mg daily (Heliocare Advanced)
Neither treatment reduced UVA-induced TT-dimers in skin (NAM: p = 0.15; PL: p = 0.15)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 480 mg daily (Heliocare Advanced)
Both NAM and PL increased MED by 26%. And A median MED of 27.7 J/cm² (13.4-51.1 J/cm²) pre-PL and 34.8 J/cm² (16.4-62.5 J/cm²) post-PL (p = 0.0002).
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 480 mg daily (Heliocare Advanced)
Neither treatment reduced UVA-induced TT-dimers in ... urine (NAM: p = 0.89; PL: p = 0.30).
- Effect
- Neutral
- Effect size
- Small
- Dose
- 480 mg daily (Heliocare Advanced)